AIM
AIM
AMEX · Biotechnology

Aim Immunotech Inc

$0.37
+0.01 (+3.00%)
As of Jun 24, 10:17 PM ET ·
Analyst Consensus
Strong Buy
6
Analysts
Moderate
Coverage
Buy 5 83%
Hold 1 17%
Sell 0 0%
Price Target
Analyst Price Target +5,809.1% upside
Low Target $15.13
Average Target $22.10
High Target $31.02
Current Price $0.37
Current
$0.37
Target
$22.10
$15.13 $22.10 avg $31.02
Scenario Analysis
Bear Case
$15.13
3,945.5%
Low target
Base Case
$22.10
+5,809.1%
Avg target
Bull Case
$31.02
+8,194.1%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$19.74
-98.1% from high
52-Week Low
$0.21
+78.1% from low
Target vs 52W High
$22.10
+12.0% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 40 78% $257.58 +9.7%
AMGN
Amgen Inc
Hold 44 50% $190.87 -45.7%
GILD
Gilead Sciences Inc
Strong Buy 39 82% $362.68 +189.8%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 40 83% $438.34 -7.8%
REGN
Regeneron Pharmaceuticals
Buy 38 71% $76.80 -87.7%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 37 76% $102.31 -65.2%
RVMD
Revolution Medicines Inc
Strong Buy 27 96% $114.11 -32.8%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -45.0%